NEW YORK and SAN DIEGO, April 02, 2020 (GLOBE NEWSWIRE) — Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company […]
Implements Temporary Cost Saving Initiatives, Including Executive Compensation ReductionTemporarily Postpones May Quarterly DividendLiquidity Position Remains SolidGARDEN CITY, N.Y., April 02, [...]